Using a rigorously calibrated mathematical model informed by in vivo data, we identify an optimal RT dose range (6 to 8 Gy) that maximizes ICD and reveal that SIRPα-CD47 checkpoint inhibition transforms radiation-induced tumor cell death into a potent systemic immune stimulus. Here, SIRPA is linked to neoplasm.